Literature DB >> 10093943

Predictors of physician compliance with a published guideline on management of febrile infants.

D M Zerr1, M A Del Beccaro, P Cummings.   

Abstract

BACKGROUND: Previous studies have demonstrated clinicians' poor compliance with published management strategies and protocols, but the reasons why physicians often choose to vary their management of the febrile infant from published guidelines are poorly understood.
OBJECTIVE: We conducted a study of physicians to learn more about the issues that influence their decisions in the management of febrile infants.
METHODS: A survey study of pediatricians, emergency physicians and family physicians randomly selected from a list of licensed physicians in the United States. Chi square and Kruskal-Wallis tests were used to measure differences in responses by specialty. Odds ratios from logistic regression were used to measure differences in compliance with a recently published guideline.
RESULTS: We received 193 completed surveys from pediatricians, 177 from emergency physicians and 104 from family physicians. After controlling for other variables, odds for compliance with a recently published guideline were higher for pediatricians [odds ratio (OR) = 9.13] and emergency physicians (OR = 2.5) than for family physicians (P < 0.001). Factors associated with decreased odds of compliance included more years since graduation from medical school (OR = 0.93), a higher proportion of office visits by children < 1 year of age (OR = 0.97) and increased comfort diagnosing serious bacterial illness (OR = 0.35). Factors associated with increased odds of compliance included a higher perceived likelihood of serious bacterial illness in febrile infants (OR = 1.01) and better reported knowledge of the recently published guideline (OR = 2.01).
CONCLUSIONS: We found that specialty as well as other factors were associated with physician compliance with a recently published guideline. This information may facilitate guideline development and implementation by providing a better understanding of what motivates physicians in their clinical decision making.

Entities:  

Mesh:

Year:  1999        PMID: 10093943     DOI: 10.1097/00006454-199903000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  National trends in emergency department use of urinalysis, complete blood count, and blood culture for fever without a source among children aged 2 to 24 months in the pneumococcal conjugate vaccine 7 era.

Authors:  Alan E Simon; Susan L Lukacs; Pauline Mendola
Journal:  Pediatr Emerg Care       Date:  2013-05       Impact factor: 1.454

2.  Costs and infant outcomes after implementation of a care process model for febrile infants.

Authors:  Carrie L Byington; Carolyn C Reynolds; Kent Korgenski; Xiaoming Sheng; Karen J Valentine; Richard E Nelson; Judy A Daly; Russell J Osguthorpe; Brent James; Lucy Savitz; Andrew T Pavia; Edward B Clark
Journal:  Pediatrics       Date:  2012-06-25       Impact factor: 7.124

3.  Factors Associated With Dispensing Dosage Delivery Devices.

Authors:  Eva Wojewoda; Katherine J Chou
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

4.  Approach to the febrile child: A challenge bridging the gap between the literature and clinical practice.

Authors:  Jean-Bernard Girodias; Benoit Bailey
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

5.  Use of Procalcitonin in a Febrile Infant Clinical Pathway and Impact on Infants Aged 29 to 60 Days.

Authors:  Kaitlin Widmer; Sarah Schmidt; Leigh Anne Bakel; Michael Cookson; Jan Leonard; Amy Tyler
Journal:  Hosp Pediatr       Date:  2021-03

6.  Emergency department crowding and time to antibiotic administration in febrile infants.

Authors:  Jennifer K Light; Robyn M Hoelle; Jill Boylston Herndon; Wei Hou; Marie-Carmelle Elie; Kelly Jackman; J Adrian Tyndall; Donna L Carden
Journal:  West J Emerg Med       Date:  2013-09

7.  Factors influencing current low-value follow-up care after basal cell carcinoma and suggested strategies for de-adoption: a qualitative study.

Authors:  S van Egmond; M Wakkee; A van Rengen; M T Bastiaens; T Nijsten; M Lugtenberg
Journal:  Br J Dermatol       Date:  2019-03-28       Impact factor: 9.302

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.